StockData
Aytu BioPharma, Inc logo

Aytu BioPharma, Inc (AYTU) stock

AYTUNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 22, 2026Score 9/3079% below fair value
$1.78−0.01 (-0.56%)

Close on Nov 13, 2026Market cap $19.34MP/E –Yield –

Aytu BioPharma EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Aytu BioPharma's EV/EBITDA was 2.8× on Jul 31, 2025, against 6.1× a year earlier.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2025Jul 31, 20252.8×+1.4
2024Dec 31, 20241.4×–

More Aytu BioPharma figures

See a number that looks wrong?